Three Immunological Elephants in the Public Health Room

Three Immunological Elephants in the Public Health Room

Voice for Science and Solidarity General Manager | The biggest challenge in vaccinology: Countering immune evasion

Sep. 1, 2026, 12:30 a.m.

How immunological blind spots underlying the pro-vax/anti-vax divide fuel polarization and obscure the biology that should guide risk-benefit assessment.

When it comes to understanding the interaction between viruses causing acute, self-limiting infections (ASLVI) and the immune system of vertebrate populations, three fundamentally important dynamics remain strikingly poorly understood ? or, at the very least, poorly integrated into mainstream thinking:

herd immune protection, viral immune escape, and epigenetic training of genetically unrestricted humoral and cell-mediated innate immunity.

These are not peripheral immunological curiosities. All three are critical to understanding how epidemics and pandemics are eventually tamed by natural immunity and why antigen-specific immunization practices, except for those relying on gene therapy, can only be safely and effectively applied prophylactically.

Because the dynamics and interplay of these three phenomena are insufficiently understood, they have become the elephants in the room whenever public-health authorities and their experts discuss epidemic or pandemic control. However, when population-level immune pressure is capable of altering viral fitness landscapes, when innate immunity itself can be functionally reprogrammed by previous exposure and when herd immunity is an evolving line of collective immune defense rather than merely the sum of individual antibody titers, intervention strategies cannot rationally be evaluated in isolation from those dynamics.

And that ignorance comes at a very high price.

The failure to understand this ‘holy trinity’ of protective herd immunity, viral immune escape and trained innate immunity continues to fuel the extraordinary polarization and sterile confrontation between ‘pro-vax’ and ‘anti-vax’ camps. Ironically, neither side seems to recognize that this very lack of understanding lies at the heart of their fundamental disagreement over the risk–benefit assessment of social and immune interventions intended to prevent or control epidemics and pandemics ? and, ultimately, over their consequences for human health.

The resulting polarization of recent years is therefore more than socially destructive. It has become a formidable obstacle to rational public-health policy and scientific progress. It discourages precisely the kind of open, multidisciplinary debate required to determine when vaccination, antivirals, behavioral measures or other interventions are likely to provide the greatest benefit with the least biological and societal cost.

Instead, the debate has now become trapped in a scientifically impoverished choice between ‘black’ and ‘white’, while the biology itself operates through dynamic interactions, changing immune landscapes and viral evolutionary feedback.

If the immunological and evolutionary consequences of an intervention are incompletely understood, then its health impact cannot be adequately assessed by looking only at its immediate or directly measurable effects.

A scientifically meaningful risk-benefit analysis must also ask how an intervention modifies the host–pathogen relationship at population level, how those changes affect viral evolution and immune protection over time, and whether the resulting trajectory increases or decreases risk relative to benefit for both the individual and the population.

This is precisely why the central question should never simply be whether one is ‘for’ or ‘against’ vaccination, infection-control measures or any other intervention. The scientifically meaningful question is:

Under a given epidemiological and immunological context, which intervention, or combination of interventions, produces the most favorable overall risk–benefit outcome, both for the individual and for the population?

That is the discussion we should have been having all along!
Answering that question requires far more than performing conventional epidemiological, virological and serological surveillance, characterizing viral genetic evolution and defining immune correlates of individual protection.

It also requires understanding how population-level immunological and evolutionary dynamics shape the evolutionary and epidemiological course of an epidemic or pandemic, how such outbreaks are naturally brought under control, resolve, or transition toward endemicity, and how such outbreaks may be prevented or their trajectory altered or mitigated through social measures and/or immune interventions.

Without such an integrated understanding, it is far more difficult to identify strategies that genuinely reduce health risk relative to benefit ? both in the short and longer term, and at the level of both the individual and the population. Consequently, public-health and medical interventions risk being designed around only part of the biological system they are intended to influence.

This is where the immunological naïveté of the two camps ? together with the failure of those shaping public health policy to adequately integrate a multidisciplinary perspective ? becomes more than an academic problem.

It becomes a practical impediment to developing safer and more effective interventions.

The fiercer the fight over ‘black’ versus ‘white’, the less room remains for the scientific question that actually matters:

under which conditions does a given intervention help, under which conditions may it become counterproductive, and how can its risk–benefit profile be optimized?

One side too often treats questioning vaccination strategy as inherently ‘anti-vaccine’. The other too often treats vaccination itself as inherently misguided. Both positions risk replacing biological reasoning with ideological reflex.

Meanwhile, the much harder, and much more important, scientific question remains insufficiently addressed.

Only through a deep, intellectually humble and respectful understanding of how natural immunity regulates epidemics and pandemics caused by ASLVI can we design intervention strategies that are as safe and as effective as possible under any given epidemiological circumstances.

That requires abandoning tribal labels, restoring genuine scientific debate and being prepared to follow the biology wherever it leads ? even when the conclusions are uncomfortable to one camp or the other.

Public health should indeed not be about defending a camp. It should be about achieving the best possible health outcome with the lowest possible risk ? for individuals and for society.

‍